Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes

被引：0

作者：

Haupt, A

Eckert, H

Schweitzer, MA

Peiker, J

Häring, HU

Fritsche, A

机构：

[1] Aventis Pharma Deutschland GmbH, Bad Soden am Taunus, Germany

[2] Univ Tubingen, Med Klin, D-7400 Tubingen, Germany

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

743

引用

页码：A269 / A269

页数：1

共 50 条

[41] Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente
Scholtz, HE
Becker, RHA
DIABETES, 2004, 53 : A481 - A481
[42] Insulin therapy in type 2 diabetes: A prospective 18 month comparison of insulin glargine and NPH insulin in patients with a multiple injection regimen
Siegmund, T
Born, T
Weber, S
Usadel, KH
Schumm-Draeger, PM
DIABETES, 2003, 52 : A456 - A456
[43] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
Haak, T
Tiengo, A
Draeger, E
Suntum, M
Waldhäusl, W
DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
[44] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan, P.
Poole, C. D.
Holmes, P.
Tetlow, A. P.
Currie, C. J.
VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
[45] Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus
Schober, E
Schoenle, E
Van Dyk, J
Wernicke-Panten, K
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 (04): : 369 - 376
[46] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A345 - A345
[47] A randomized, multicentre trial of insulin glargine versus NPH insulin in people with Type 1 diabetes.
Home, P
DIABETOLOGIA, 2002, 45 : A258 - A258
[48] Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy:: Comparison of insulin glargine with NPH insulin as basal insulin supplement
Ploeckinger, Ursula
Topuz, Mendaha
Riese, Brigitte
Reuter, Thomas
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 290 - 295
[49] MAGE revisited: Evaluation of glucose variability with once daily glargine vs NPH insulin in type 2 diabetes
Silvani, G.
Acquati, S.
Manini, R.
Ragazzini, C.
Taroni, S.
Donadio, F.
Buci, L.
Gagliardi, L.
Tartaglia, A.
Nizzoli, M.
DIABETOLOGIA, 2010, 53
[50] Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
Delgado, E.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 281 - 288

← 1 2 3 4 5 →